Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets

Danaher is back in focus as analysts edge price targets into the US$240 to US$255 range, with some models now centering around fair value of about US$244.14. This shift reflects recent research that is divided between optimism on improving demand in life science tools and diagnostics, and concern that current valuations may already factor in a recovery, especially around bioprocessing. In the sections that follow, you will see how these updated targets fit into the broader narrative and what...